The epiMelanoma test enables plasma-based detection of melanoma and prediction of immunotherapy response
Abstract Background Melanoma is one of the most serious skin cancers worldwide, often progressing without obvious symptoms. Early detection is crucial to enable timely intervention, reducing morbidity and mortality. However, no standardized high-throughput test exists for non-invasive melanoma detec...
Saved in:
| Main Authors: | Olivia Dumas, Nicholas Rozza, David Cheishvili, Sharon Luk, Sarah T. K. Sin, Alua Khassenova, Richard Kremer, Moshe Szyf, Catalin Mihalcioiu, Shafaat A. Rabbani |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Nature Portfolio
2025-08-01
|
| Series: | Scientific Reports |
| Subjects: | |
| Online Access: | https://doi.org/10.1038/s41598-025-13952-x |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Epigenetic Therapies in Melanoma—Targeting DNA Methylation and Histone Modification
by: Adrian Bogdan Tigu, et al.
Published: (2025-05-01) -
Metabolic Reprogramming in Melanoma: An Epigenetic Point of View
by: Stefano Giuliani, et al.
Published: (2025-06-01) -
Epigenetic modifiers to enhance the efficacy of immune checkpoint inhibitors for the treatment of melanoma
by: Luigi Liguori, et al.
Published: (2025-09-01) -
Current treatment strategy for resectable scalp and neck melanoma
by: A. P. Polyakov, et al.
Published: (2021-08-01) -
The Role of Human Endogenous Retroviruses in the Initiation and Progression of Melanoma
by: Yao Lin, et al.
Published: (2025-07-01)